Ultrasound therapy
US7481781B2 · kind B2 · utility
3Cited by
17References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 16, 2003 |
| Grant date | Jan 27, 2009 |
| Priority date | — |
| Expiry date | Sep 2, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N2007/0008
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described and claimed is the combined use of an electric field and ultrasound to ablate a cell or tissue, the use of ultrasound to disrupt a nucleated cell which has previously been electrosensitised by exposure to an electric field, and the use of an electric field for sensitising a nucleated cell to ultrasound. We furthermore disclose the use of electricity to disrupt a nucleated cell which has previously been sensitised by exposure to ultrasound, and the use of ultrasound for sensitising a nucleated cell to electricity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.